Deletion of a Mycobacterium tuberculosis proteasomal ATPase homologue gene produces a slow-growing strain that persists in host tissues

Journal of Infectious Diseases

Volumn 194, Issue 9, 2006, Pages 1233-1240

  Lamichhane, Gyanu ^a   Raghunand, Tirumalai R ^a   Morrison, Norman E ^a   Woolwine, Samuel C ^a   Tyagi, Sandeep ^a   Kaudavelou, Karthikeyan ^a   Bishai, William R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; GAMMA INTERFERON; GENE PRODUCT; PROTEASOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE DELETION; GENE EXPRESSION; GROWTH RATE; HOST; IN VITRO STUDY; IN VIVO STUDY; LAT GENE; LETHALITY; LUNG PARENCHYMA; MOUSE; MT2175 GENE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; UPREGULATION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BACTERIAL PROTEINS; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; IMMUNIZATION; IMMUNOCOMPETENCE; INTERFERON TYPE II; LUNG; MICE; MYCOBACTERIUM TUBERCULOSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; TUBERCULOSIS; UP-REGULATION; VIRULENCE;

EID: 33750380805     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/508288     Document Type: Article

References (32)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC, Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282:677-86.
2. Mitchison DA. Tuberculosis hits back. Nature 2004; 427:295.
3. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346:1339-45.
4. Larson CL, Wicht WC. Studies of resistance to experimental tuberculosis in mice vaccinated with living attenuated tubercle bacilli and challenged with virulent organisms. Am Rev Respir Dis 1962; 85:833.
5. North RJ, Izzo AA. Mycobacterial virulence: virulent strains of Mycobacterium tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity. J Exp Med 1993; 177:1723-33.
6. Wolf S, Nagy I, Lupas A, et al. Characterization of ARC, a divergent member of the AAA ATPase family from Rhodococcus erythropolis. J Mol Biol 1998; 277:13-25.
7. Zwickl P. The 20S proteasome. In: Baumeister W, ed. The proteasome-ubiquitin protein degradation pathway. Vol. 268. Berlin: Springer, 2002: 23-41.
8. De Mot R, Nagy I, Walz J, Baumeister W. Proteasomes and other self-compartmentalizing proteases in prokaryotes. Trends Microbiol 1999; 7:88-92.
9. Darwin KH, Lin G, Chen Z, Li H, Nathan CF. Characterization of a Mycobacterium tuberculosis proteasomal ATPase homologue. Mol Microbiol 2005; 55:561-71.
10. Darwin KH, Ehrt S, Gutierrez-Ramos JC, Weich N, Nathan CF. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 2003; 302:1963-6.
11. Valway SE, Sanchez MP, Shinnick TF, et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 1998; 338:633-9.
12. Hatfull G, Jacobs WR Jr. Molecular genetics of mycobacteria. Washington, DC: American Society for Microbiology Press, 2000.
13. Bardarov S, Bardarov S Jr, Pavelka MS Jr, et al. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 2002; 148:3007-17.
14. Lee MH, Pascopella L, Jacobs WR Jr, Hatfull GF. Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guerin. Proc Natl Acad Sci USA 1991; 88:3111-5.
15. Lamichhane G, Zignol M, Blades NJ, et al. A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2003; 100:7213-8.
16. Hingley-Wilson SM, Sambandamurthy VK, Jacobs WR Jr. Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nat Immunol 2003; 4:949-55;
17. Kaushal D, Schroeder BG, Tyagi S, et al. Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc Natl Acad Sci USA 2002; 99:8330-5.
18. Sun R, Converse PJ, Ko C, Tyagi S, Morrison NE, Bishai WR. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set. Mol Microbiol 2004; 52:25-38.
19. Dahl JL, Kraus CN, Boshoff HI, et al. The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc Natl Acad Sci USA 2003; 100:10026-31.
20. Davis EO, Dullaghan EM, Rand L Definition of the mycobacterial SOS box and use to identify LexA-regulated genes in Mycobacterium tuberculosis. J Bacteriol 2002; 184:3287-95.
21. Sassetti CM, Boyd DH, Rubin EJ. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 2003; 48:77-84.
22. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 2002; 43:717-31.
23. Knipfer N, Shrader TE. Inactivation of the 20S proteasome in Mycobacterium smegmatis. Mol Microbiol 1997; 25:375-83.
24. Dannenberg AM Jr. Pathogenesis of pulmonary tuberculosis. Am Rev Respir Dis 1982; 125:25-9.
25. Vilcek J, Klion A, Henriksen-DeStefano D, et al. Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis. J Clin Immunol 1986; 6:146-51.
26. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000; 11:321-33.
27. Condos R, Rom WN, Schluger NW. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet 1997; 349:1513-5.
28. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993; 259:1739-42.
29. Kamijo R, Le J, Shapiro D, et al. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 1993; 178:1435-40.
30. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:2243-7.
31. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54.
32. Sambandamurthy V, Jacobs WR Jr. Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis. Microbes Infect 2005; 7:955-61.